Related Experiment Video
Updated: May 1, 2026

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
Published on: March 30, 2019
Knocking down CDK4 mediates the elevation of let-7c suppressing cell growth in nasopharyngeal carcinoma
Zhen Liu, Xiaobin Long, Cheng Chao
1Department of Pathology, Guangzhou Medical University, Guangzhou 510182, China. yajie.zhang@163.com.
Background:
CDK4 is a protein kinase in the CDK family important for G1/S phase cell cycle progression. However, the roles and molecular mechanisms of CDK4 triggering nasopharynx carcinogenesis are still unclear.
Methods:
Lentiviral-vector mediated shRNA was used to suppress CDK4 expression and examine its molecular mechanisms. Using immunohistochemistry, we analyzed CDK4 protein expression in clinicopathologically characterized nasopharyngeal carcinoma (NPC) cases and nasopharyngeal tissues (NPs). Survival curves were plotted by the Kaplan-Meier method and compared using the log-rank test.
Results:
In this investigation, we knocked down CDK4 expression and observed that NPC cell growth and cell cycle progression were significantly blocked by suppressing expression of CCND1, CDK6, and E2F1 as well as elevated p21 expression. Further, we found that reduced CDK4 expression elevated the expression of let-7c, a tumor-suppressive miRNA modulated by E2F1. We found that let-7c was markedly downregulated in NPC tissues compared to NPs and suppressed cell growth and cell cycle progression by modulating p15/p16/CDK4/E2F1 pathway. Finally, CDK4 protein was observed to be overexpressed in NPC tissues and could be considered an unfavorable prognosis factor for NPC patients although its independent prognostic value did not reach statistical significance (p = 0.087).
Conclusions:
Our results demonstrated that overexpressed CDK4 is an unfavorable prognostic factor which suppresses the expression of tumor suppressive-factor let-7c through p21/CCND1/CDK6/E2F1 signaling, and inhibits cell proliferation by p15/p16/CDK4/E2F1 feedback signaling in NPC.
Insights
Overexpressed Cyclin-Dependent Kinase 4 (CDK4) promotes nasopharyngeal carcinoma (NPC) by suppressing let-7c microRNA and driving cell proliferation. Targeting CDK4 may offer a therapeutic strategy for NPC patients.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Cyclin-Dependent Kinase 4 (CDK4) is crucial for cell cycle progression.
- The precise role of CDK4 in nasopharyngeal carcinoma (NPC) development remains incompletely understood.
Purpose of the Study:
- To investigate the molecular mechanisms by which CDK4 contributes to nasopharyngeal carcinogenesis.
- To evaluate CDK4 as a prognostic biomarker in NPC.
Main Methods:
- Utilized lentiviral-vector mediated shRNA to suppress CDK4 expression in NPC cells.
- Analyzed CDK4 protein expression in NPC tissues and normal nasopharyngeal tissues via immunohistochemistry.
- Assessed cell growth, cell cycle progression, and miRNA expression changes following CDK4 knockdown.
- Correlated CDK4 expression with patient survival using Kaplan-Meier analysis.
Main Results:
- CDK4 knockdown significantly inhibited NPC cell growth and cell cycle progression.
- Suppression of CDK4 led to decreased expression of CCND1, CDK6, and E2F1, and increased p21 expression.
- Reduced CDK4 expression upregulated let-7c, a tumor-suppressive microRNA, which was downregulated in NPC tissues.
- Overexpressed CDK4 in NPC tissues correlated with unfavorable prognosis, though not statistically significant (p=0.087).
Conclusions:
- Overexpressed CDK4 acts as an unfavorable prognostic factor in NPC.
- CDK4 suppresses tumor-suppressive let-7c via p21/CCND1/CDK6/E2F1 signaling.
- CDK4 inhibition disrupts NPC cell proliferation through a p15/p16/CDK4/E2F1 feedback loop.
Related Concept Videos
Inhibition of Cdk Activity
Inhibition of CDK Activity
M-Cdk Drives Transition Into Mitosis
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
M-Cdk Drives Transition Into Mitosis
Positive Regulator Molecules
MicroRNAs

